Dr. Anthony Mancini, MD

NPI: 1639147002
Total Payments
$206,725
2024 Payments
$65,556
Companies
22
Transactions
140

Payment Breakdown by Category

Other$126,483 (61.2%)
Consulting$71,851 (34.8%)
Travel$4,609 (2.2%)
Food & Beverage$3,691 (1.8%)
Gifts$62.20 (0.0%)
Education$30.06 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $80,915 20 39.1%
Consulting Fee $71,851 17 34.8%
Honoraria $36,069 3 17.4%
Grant $5,000 1 2.4%
Travel and Lodging $4,609 9 2.2%
Compensation for serving as faculty or as a speaker for a medical education program $4,500 1 2.2%
Food and Beverage $3,691 83 1.8%
Gift $62.20 4 0.0%
Education $30.06 2 0.0%

Top Paying Companies

Company Total Records Latest Year
ParaPRO, LLC $73,498 5 $0 (2024)
Verrica Pharmaceuticals Inc. $41,037 18 $0 (2024)
PFIZER INC. $19,770 22 $0 (2024)
Novartis Pharmaceuticals Corporation $18,673 10 $0 (2023)
Dermavant Sciences, Inc. $16,994 9 $0 (2024)
Galderma Laboratories, L.P. $7,829 2 $0 (2024)
GENZYME CORPORATION $7,502 8 $0 (2024)
Regeneron Healthcare Solutions, Inc. $5,153 12 $0 (2024)
NOBELPHARMA AMERICA, LLC $5,107 7 $0 (2024)
Pierre Fabre Pharmaceuticals, Inc. $3,224 3 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $65,556 50 Verrica Pharmaceuticals Inc. ($39,037)
2023 $42,152 18 ParaPRO, LLC ($31,868)
2022 $38,580 23 ParaPRO, LLC ($32,858)
2021 $12,948 11 NOVARTIS PHARMACEUTICALS CORPORATION ($6,890)
2020 $20,040 8 Novartis Pharmaceuticals Corporation ($11,700)
2019 $7,600 10 PFIZER INC. ($7,418)
2018 $7,388 8 PFIZER INC. ($7,345)
2017 $12,463 12 PFIZER INC. ($4,915)

All Payment Transactions

140 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
11/27/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $29.22 General
Category: Inflammation
11/16/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Consulting Fee Cash or cash equivalent $8,580.00 General
Category: DERMATOLOGY
11/16/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Travel and Lodging In-kind items and services $282.56 General
Category: DERMATOLOGY
11/16/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Food and Beverage In-kind items and services $134.71 General
Category: DERMATOLOGY
11/16/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Food and Beverage In-kind items and services $73.62 General
Category: DERMATOLOGY
11/16/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Food and Beverage In-kind items and services $46.86 General
Category: DERMATOLOGY
11/16/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Food and Beverage In-kind items and services $41.76 General
Category: DERMATOLOGY
11/16/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Food and Beverage In-kind items and services $34.56 General
Category: DERMATOLOGY
10/30/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $37.34 General
Category: INFLAMMATION AND IMMUNOLOGY
10/26/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $87.33 General
Category: Immunology
10/25/2024 Endo USA, Inc. XIAFLEX (Biological) Food and Beverage In-kind items and services $14.50 General
Category: UROLOGY
10/24/2024 Endo USA, Inc. XIAFLEX (Biological) Food and Beverage In-kind items and services $14.49 General
Category: UROLOGY
10/04/2024 Verrica Pharmaceuticals Inc. YCANTH (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,700.00 General
Category: DERMATOLOGY
10/04/2024 Verrica Pharmaceuticals Inc. YCANTH (Drug) Travel and Lodging Cash or cash equivalent $108.54 General
Category: DERMATOLOGY
10/04/2024 Verrica Pharmaceuticals Inc. YCANTH (Drug) Food and Beverage In-kind items and services $29.06 General
Category: DERMATOLOGY
09/30/2024 Verrica Pharmaceuticals Inc. YCANTH (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $9,600.00 General
Category: DERMATOLOGY
09/18/2024 Verrica Pharmaceuticals Inc. YCANTH (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,200.00 General
Category: DERMATOLOGY
09/18/2024 Verrica Pharmaceuticals Inc. YCANTH (Drug) Travel and Lodging Cash or cash equivalent $41.54 General
Category: DERMATOLOGY
09/18/2024 Verrica Pharmaceuticals Inc. YCANTH (Drug) Food and Beverage In-kind items and services $19.76 General
Category: DERMATOLOGY
09/11/2024 COLOPLAST CORP Coloplast TFL Drive (Device) Food and Beverage In-kind items and services $25.53 General
Category: Endourology
08/28/2024 Verrica Pharmaceuticals Inc. YCANTH (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,200.00 General
Category: DERMATOLOGY
08/28/2024 Verrica Pharmaceuticals Inc. YCANTH (Drug) Travel and Lodging Cash or cash equivalent $34.84 General
Category: DERMATOLOGY
08/27/2024 PFIZER INC. CIBINQO (Drug), LITFULO Food and Beverage In-kind items and services $49.98 General
Category: Inflammation & Immunology
08/23/2024 Dermavant Sciences, Inc. TAPINAROF (Drug) Consulting Fee Cash or cash equivalent $3,900.00 General
Category: DERMATOLOGY
08/14/2024 Verrica Pharmaceuticals Inc. YCANTH (Drug) Consulting Fee Cash or cash equivalent $6,564.00 General
Category: DERMATOLOGY

About Dr. Anthony Mancini, MD

Dr. Anthony Mancini, MD is a Dermatology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639147002.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Mancini, MD has received a total of $206,725 in payments from pharmaceutical and medical device companies, with $65,556 received in 2024. These payments were reported across 140 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($80,915).

Practice Information

  • Specialty Dermatology
  • Other Specialties Pediatrics
  • Location Chicago, IL
  • Active Since 03/10/2006
  • Last Updated 09/21/2011
  • Taxonomy Code 207N00000X
  • Entity Type Individual
  • NPI Number 1639147002

Products in Payments

  • Natroba (Drug) $68,926
  • YCANTH (Drug) $41,037
  • EUCRISA (Drug) $18,270
  • TAPINAROF (Drug) $16,994
  • COSENTYX (Biological) $14,270
  • HYFTOR (Drug) $5,085
  • Natroba Topical Suspension, 0.9% (Drug) $4,572
  • DUPIXENT (Biological) $3,756
  • Cloderm Cream (Drug) $2,662
  • NOCDURNA (Drug) $130.69
  • Coloplast TFL Drive (Device) $101.17
  • COSENTYX (Drug) $82.98
  • RINVOQ (Biological) $82.20
  • XIAFLEX (Biological) $65.76
  • CIBINQO (Drug) $65.25
  • Porges Coloplast (Device) $57.84
  • OPZELURA (Drug) $49.55
  • XYOSTED (Drug) $49.01
  • Otezla (Drug) $29.22
  • Humira (Biological) $24.30

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Dermatology Doctors in Chicago